Yahoo
    BSE - Delayed Quote INR

    Laurus Labs Limited (LAURUSLABS.BO)

    1,998.00 -14.00 (-0.70%)
    At close: 3:29:24 PM GMT+5:30
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for LAURUSLABS.BO
    • Previous Close 2,012.00
    • Open 1,995.00
    • Bid 1,998.00 x --
    • Ask 2,002.00 x --
    • Day's Range 1,959.00 - 2,018.35
    • 52 Week Range 901.85 - 2,087.00
    • Volume 115,730
    • Avg. Volume 92,576
    • Market Cap (intraday) 1.08T
    • Beta (5Y Monthly) 0.34
    • PE Ratio (TTM) 98.76
    • EPS (TTM) 20.23
    • Earnings Date Oct 29, 2026
    • Forward Dividend & Yield 2.40 (0.12%)
    • Ex-Dividend Date May 8, 2026
    • 1y Target Est 1,703.07

    Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

    www.lauruslabs.com

    7,059

    Full Time Employees

    March 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Laurus Labs Limited

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/22/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

    YTD Return

    LAURUSLABS.BO
    80.47%
    S&P BSE SENSEX (^BSESN)
    14.05%

    1-Year Return

    LAURUSLABS.BO
    117.40%
    S&P BSE SENSEX (^BSESN)
    13.24%

    3-Year Return

    LAURUSLABS.BO
    402.97%
    S&P BSE SENSEX (^BSESN)
    12.01%

    5-Year Return

    LAURUSLABS.BO
    277.93%
    S&P BSE SENSEX (^BSESN)
    20.43%

    Earnings Trends

    View More

    Earnings Per Share

    GAAP
    Normalized
    GAAP
    Normalized

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q4 FY26
    Revenue 18.12B
    Earnings 2.79B
    Profit Margin 15.41%

    Q1

    FY26

    Q2

    FY26

    Q3

    FY26

    Q4

    FY26

    0
    5B
    10B
    15B
    11.0%
    12.0%
    13.0%
    14.0%
    15.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    900.00 Low
    1,703.07 Average
    1,998.00 Current
    2,520.00 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual
    As of 9/23/2026

    • Market Cap

      1.10T

    • Enterprise Value

      1.12T

    • Trailing P/E

      100.58

    • Forward P/E

      --

    • PEG Ratio (5yr expected)

      --

    • Price/Sales (ttm)

      15.33

    • Price/Book (mrq)

      20.74

    • Enterprise Value/Revenue

      15.65

    • Enterprise Value/EBITDA

      54.07

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      15.04%

    • Return on Assets (ttm)

      --

    • Return on Equity (ttm)

      --

    • Revenue (ttm)

      72.7B

    • Net Income Avi to Common (ttm)

      10.93B

    • Diluted EPS (ttm)

      20.23

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.14B

    • Total Debt/Equity (mrq)

      46.37%

    • Levered Free Cash Flow (ttm)

      --

    View More

    Compare

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    LAURUSLABS.BO
    Laurus Labs Limited
    1,998.00
    -0.70%
    Mkt Cap INR 1.08T
    Industry Drug Manufacturers—Specialty & Generic
    GLENMARK.BO
    Glenmark Pharmaceuticals Limited
    2,183.10
    -0.99%
    Mkt Cap INR 616.125B
    Industry Drug Manufacturers—Specialty & Generic
    AMRUTANJAN.BO
    Amrutanjan Health Care Limited
    495.80
    +0.14%
    Mkt Cap INR 14.329B
    Industry Drug Manufacturers—Specialty & Generic
    PBV.F
    Prestige Consumer Healthcare Inc.
    42.00
    -0.94%
    Mkt Cap EUR 1.99B
    Industry Drug Manufacturers—Specialty & Generic
    ALKEM.BO
    Alkem Laboratories Limited
    4,982.80
    +0.36%
    Mkt Cap INR 595.768B
    Industry Drug Manufacturers—Specialty & Generic
    ORCHPHARMA.NS
    Orchid Pharma Limited
    875.55
    -1.28%
    Mkt Cap INR 44.407B
    Industry Drug Manufacturers—Specialty & Generic
    APLLTD.BO
    Alembic Pharmaceuticals Limited
    780.70
    -0.95%
    Mkt Cap INR 153.457B
    Industry Drug Manufacturers—Specialty & Generic
    GRANULES.BO
    Granules India Limited
    816.80
    +1.70%
    Mkt Cap INR 198.212B
    Industry Drug Manufacturers—Specialty & Generic
    JUBLPHARMA.BO
    Jubilant Pharmova Limited
    935.75
    +0.61%
    Mkt Cap INR 148.211B
    Industry Drug Manufacturers—Specialty & Generic
    COHANCE.BO
    Cohance Lifesciences Limited
    455.90
    -0.77%
    Mkt Cap INR 174.426B
    Industry Drug Manufacturers—Specialty & Generic
    004310.KS
    Hyundai Pharmaceutical Co., Ltd.
    6,990.00
    -7.66%
    Mkt Cap KRW 216.105B
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    GRANULES.BO Granules India Limited
    816.80 +1.70%
    DIVISLAB.BO Divi's Laboratories Limited
    9,118.75 -0.34%
    AUROPHARMA.BO Aurobindo Pharma Limited
    1,626.00 +3.16%
    SYNGENE.BO Syngene International Limited
    372.60 -0.98%
    NATCOPHARM.BO NATCO Pharma Limited
    785.50 +0.08%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: